Functional and mechanistic interrogation of alpha neurexin extracellular domains
α神经毒素细胞外结构域的功能和机制研究
基本信息
- 批准号:9901552
- 负责人:
- 金额:$ 37.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAffinityAllelesAlternative SplicingAmino AcidsBindingBiochemicalBiologicalBiological AssayCell Adhesion MoleculesCellular AssayCodeCognition DisordersCommunicationDataDiagnosisDiseaseEGF geneElectron MicroscopyElectrophysiology (science)EpilepsyEtiologyExcitatory SynapseExonsExtracellular DomainFamilyFunctional disorderGenesGenomic SegmentGonadal Steroid HormonesHippocampus (Brain)ImpairmentIn VitroIndividualInhibitory SynapseInjectionsIntellectual functioning disabilityLaboratoriesLamininLengthLigand BindingLigandsLightLinkMasksMeasuresMediatingMental disordersMessenger RNAMissense MutationMolecularMorphologyMusMutationNeurodevelopmental DisorderNeuronsPatientsPhenotypePlayPoint MutationPropertyProtein FamilyProtein IsoformsProteinsRNA SplicingRoleSchizophreniaShapesSiteSliceSpecificityStructureSurfaceSynapsesSynaptic TransmissionSynaptic plasticityTestingautism spectrum disorderbasecombinatorialextracellularimmunocytochemistryin vivoinsightinterdisciplinary approachknock-downmutantneuroligin 1neuropsychiatric disorderoverexpressionpostsynapticpresynapticsmall hairpin RNAstemsynaptic functiontraffickingtransmission process
项目摘要
Neurexins (Nrxns) are a family of essential but poorly understood presynaptic cell-adhesion molecules that are
frequently linked to neuropsychiatric and neurodevelopmental disorders such as autism spectrum disorders
(ASDs), schizophrenia and intellectual disability (ID). Three evolutionarily conserved neurexin genes produce
longer alpha and shorter beta neurexin mRNAs that undergo extensive alternative splicing. α- and β-Nrxns
share common transmembrane and cytoplasmic sequences but differ in the length and complexity of their
extracellular domains (ECDs; 9 α-Nrxn domains compared to 1 β-Nrxn domain). Individual α-Nrxns are
associated with distinct neuropsychiatric disorders and disease-relevant mutations are commonly located in
genomic regions that code for α-Nrxn-specific extracellular sequences, suggesting that individual alpha
neurexin ECDs may control distinct aspects of synapse function. Despite their discovery over twenty years
ago, the fundamental question regarding the essential role of individual α-Nrxn ECDs at the synapse remains
unresolved. As an important first step in understanding how α-Nrxn-specific extracellular sequences function at
the synapse, our laboratory has identified an Nrxn3α compound heterozygous patient with profound ID and
epilepsy. One allele produces a non-functional protein and the second harbors a missense mutation in an
extracellular sequence shared by all α-Nrxns. Intriguingly, there are multiple ASD associated mutations in the
equivalent region of Nrxn1α indicating that this region plays an important role at the synapse. Preliminary data
from primary neurons and ex vivo acute slices revealed that expression of the missense Nrxn3α mutant
produced striking morphological and functional phenotypes at excitatory and inhibitory synapses.
Biochemically, the Nrxn3α missense mutation unexpectedly differentially modulated binding to two excitatory
postsynaptic ligands. Based on our preliminary data, we hypothesize that extracellular sequences of individual
alpha neurexins control distinct aspects of excitatory and inhibitory synapse function. Here, we will test our
central hypothesis in three specific aims: 1. Determine the impact of Nrxn3α extracellular sequences on
synaptic morphology and function in in vitro neuron cultures; 2. Biochemically assess how the Nrxn3α
missense mutation affects transsynaptic binding; and 3. Manipulate Nrxn3α ECD in vivo and assess its impact
on basal excitatory and inhibitory synaptic transmission and activity-dependent plasticity in ex vivo slices. To
accomplish aims 1 and 3, we will use molecular replacement, shRNA-mediated knockdown of endogenous
Nrxn3α and replacement with wild-type or mutant Nrxn3α to faithfully recapitulate the disease state, combined
with immunocytochemistry, electrophysiology and electron microscopy. Aim 2 will use in vitro biochemical and
structure/function approaches to measure binding affinities to known Nrxn ligands. These aims will provide first
insight into the morphological, functional and biochemical properties of Nrxn3α extracellular sequences and
how mutations in this region contribute to cognitive disease.
神经毒素(Nrxns)是一个重要的但知之甚少的突触前细胞粘附分子家族,
通常与神经精神和神经发育障碍有关,
(ASD),精神分裂症和智力残疾(ID)。三个进化上保守的neurexin基因产生
较长的α和较短的β neurexin mRNA经历广泛的选择性剪接。α-和β-Nrxns
共有共同的跨膜和胞质序列,但其长度和复杂性不同,
细胞外结构域(ECD; 9个α-Nrxn结构域与1个β-Nrxn结构域相比)。单个α-Nrxns为
与不同的神经精神疾病和疾病相关的突变通常位于
编码α-Nrxn特异性细胞外序列的基因组区域,表明个体α-Nrxn
neurexin ECD可以控制突触功能的不同方面。尽管他们发现了二十多年
以前,关于单个α-Nrxn ECDs在突触中的重要作用的基本问题仍然存在
悬而未决作为了解α-Nrxn特异性细胞外序列在细胞内如何发挥作用的重要的第一步,
我们的实验室已经确定了一个Nrxn 3 α复合杂合子患者具有深刻的ID,
癫痫一个等位基因产生一种无功能的蛋白质,第二个等位基因在一个基因中含有一个错义突变。
所有α-Nrxns共有的胞外序列。有趣的是,有多个ASD相关的突变,
Nrxn 1 α的等效区域表明该区域在突触中起重要作用。初步数据
从原代神经元和离体急性切片中发现,错义Nrxn 3 α突变体的表达
在兴奋性和抑制性突触上产生显著的形态和功能表型。
在生物化学上,Nrxn 3 α错义突变出乎意料地差异调节了与两种兴奋性受体的结合。
突触后配体基于我们的初步数据,我们假设个体的细胞外序列
α神经毒素控制兴奋性和抑制性突触功能的不同方面。在这里,我们将测试我们的
中心假设在三个具体目标:1。确定Nrxn 3 α胞外序列对
体外神经元培养中突触形态和功能; 2.生物化学评估Nrxn 3 α
错义突变影响跨突触结合;和3.在体内操纵Nrxn 3 α ECD并评估其影响
对离体切片中的基础兴奋性和抑制性突触传递以及活性依赖性可塑性的影响。到
为了实现目标1和3,我们将使用分子置换,shRNA介导的内源性敲低,
Nrxn 3 α和用野生型或突变型Nrxn 3 α替换以忠实地再现疾病状态,组合
免疫细胞化学、电生理学和电子显微镜检查。目标2将使用体外生化和
结构/功能方法来测量与已知Nrxn配体的结合亲和力。这些目标将首先提供
深入了解Nrxn 3 α胞外序列的形态、功能和生化特性,
这个区域的突变是如何导致认知疾病的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason Aoto其他文献
Jason Aoto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason Aoto', 18)}}的其他基金
Control of subsynaptic domain organization and nanocolumn alignment by neurexin-3
neurexin-3 控制突触亚域组织和纳米柱排列
- 批准号:
10429177 - 财政年份:2022
- 资助金额:
$ 37.98万 - 项目类别:
Control of subsynaptic domain organization and nanocolumn alignment by neurexin-3
neurexin-3 控制突触亚域组织和纳米柱排列
- 批准号:
10584530 - 财政年份:2022
- 资助金额:
$ 37.98万 - 项目类别:
Functional and mechanistic interrogation of alpha neurexin extracellular domains
α神经毒素细胞外结构域的功能和机制研究
- 批准号:
10377418 - 财政年份:2018
- 资助金额:
$ 37.98万 - 项目类别:
Synaptic Dissection of Cell Adhesion Molecule Function within Subicular Circuits
毛细血管内细胞粘附分子功能的突触解剖
- 批准号:
9171969 - 财政年份:2016
- 资助金额:
$ 37.98万 - 项目类别:
Synaptic Dissection of Cell Adhesion Molecule Function within Subicular Circuits
毛细血管内细胞粘附分子功能的突触解剖
- 批准号:
8679649 - 财政年份:2014
- 资助金额:
$ 37.98万 - 项目类别:
Synaptic Dissection of Cell Adhesion Molecule Function within Subicular Circuits
毛细血管内细胞粘附分子功能的突触解剖
- 批准号:
8827859 - 财政年份:2014
- 资助金额:
$ 37.98万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.98万 - 项目类别:
Research Grant